Literature DB >> 11139633

Telomeric repeat amplification, without shortening or lengthening of the telomerase products: a method to analyze the processivity of telomerase enzyme.

I Szatmari1, J Aradi.   

Abstract

The Telomeric Repeat Amplification Protocol (TRAP) and its modified versions (including ours, TP-TRAP) change the size and/or the ratio of the telomerase products in the amplification stage of the assay. Based on our recently published method we developed a new TRAP. This method ensures that the number of telomeric repeats present in the original telomerase products does not change on PCR amplification. The usefulness of the method was proved with amplification of chemically synthesized telomerase products and a newly designed telomerase substrate oligonucleotide. This is the first report in which the PCR products directly reflect the size distribution of telomerase products generated by the enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139633      PMCID: PMC29684          DOI: 10.1093/nar/29.2.e3

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  11 in total

1.  Modified telomeric repeat amplification protocol: a quantitative radioactive assay for telomerase without using electrophoresis.

Authors:  I Szatmari; S Tókés; C B Dunn; T J Bardos; J Aradi
Journal:  Anal Biochem       Date:  2000-06-15       Impact factor: 3.365

2.  Telomerase assay using biotinylated-primer extension and magnetic separation of the products.

Authors:  D Sun; L H Hurley; D D Von Hoff
Journal:  Biotechniques       Date:  1998-12       Impact factor: 1.993

3.  Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).

Authors:  N W Kim; F Wu
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

4.  Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay.

Authors:  G Krupp; K Kühne; S Tamm; W Klapper; K Heidorn; A Rott; R Parwaresch
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

5.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.

Authors:  G B Morin
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

6.  Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.

Authors:  C W Greider; E H Blackburn
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

Review 7.  Applications of telomerase research in the fight against cancer.

Authors:  K E McKenzie; C B Umbricht; S Sukumar
Journal:  Mol Med Today       Date:  1999-03

Review 8.  Role of telomerase in cellular proliferation and cancer.

Authors:  S E Holt; J W Shay
Journal:  J Cell Physiol       Date:  1999-07       Impact factor: 6.384

9.  A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.

Authors:  K Tatematsu; J Nakayama; M Danbara; S Shionoya; H Sato; M Omine; F Ishikawa
Journal:  Oncogene       Date:  1996-11-21       Impact factor: 9.867

10.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

View more
  12 in total

1.  Small circular DNAs for synthesis of the human telomere repeat: varied sizes, structures and telomere-encoding activities.

Authors:  Jörg S Hartig; Eric T Kool
Journal:  Nucleic Acids Res       Date:  2004-11-01       Impact factor: 16.971

2.  Telomerase dependence of telomere lengthening in Ku80 mutant Arabidopsis.

Authors:  Maria Eugenia Gallego; Nicole Jalut; Charles I White
Journal:  Plant Cell       Date:  2003-03       Impact factor: 11.277

3.  Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.

Authors:  Tara J Moriarty; Delphine T Marie-Egyptienne; Chantal Autexier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

4.  The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity.

Authors:  Sylvain Huard; Tara J Moriarty; Chantal Autexier
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

5.  Artificial human telomeres from DNA nanocircle templates.

Authors:  Ulf M Lindstrom; Ravi A Chandrasekaran; Lucian Orbai; Sandra A Helquist; Gregory P Miller; Emin Oroudjev; Helen G Hansma; Eric T Kool
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

6.  Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan.

Authors:  Andrei Seluanov; Christopher Hine; Michael Bozzella; Amelia Hall; Tais H C Sasahara; Antonio A C M Ribeiro; Kenneth C Catania; Daven C Presgraves; Vera Gorbunova
Journal:  Aging Cell       Date:  2008-09-05       Impact factor: 9.304

7.  MERISTEM DISORGANIZATION1 encodes TEN1, an essential telomere protein that modulates telomerase processivity in Arabidopsis.

Authors:  Katherine A Leehy; Jung Ro Lee; Xiangyu Song; Kyle B Renfrew; Dorothy E Shippen
Journal:  Plant Cell       Date:  2013-04-09       Impact factor: 11.277

8.  Telomere- and telomerase-interacting protein that unfolds telomere G-quadruplex and promotes telomere extension in mammalian cells.

Authors:  Feng Wang; Ming-liang Tang; Zhi-xiong Zeng; Ren-yi Wu; Yong Xue; Yu-hua Hao; Dai-wen Pang; Yong Zhao; Zheng Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

9.  POT1a and components of CST engage telomerase and regulate its activity in Arabidopsis.

Authors:  Kyle B Renfrew; Xiangyu Song; Jung Ro Lee; Amit Arora; Dorothy E Shippen
Journal:  PLoS Genet       Date:  2014-10-16       Impact factor: 5.917

10.  Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro.

Authors:  Gérald Gavory; Mark Farrow; Shankar Balasubramanian
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.